Ligand Pharmaceuticals Inc financial data

Symbol
LGND on Nasdaq, LGNDZ, LGNXZ, LGNYZ, LGNZZ on OTC
Industry
Pharmaceutical Preparations
Location
3911 Sorrento Valley Blvd, Suite 110, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
LIGAND PHARMACEUTICALS (to 9/13/1994)
Latest financial report
10-K - Q4 2024 - Feb 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.35K % +97.4%
Quick Ratio 72.1 % +28.5%
Debt-to-equity 13 % -21.7%
Return On Equity -0.5 % -106%
Return On Assets -0.44 % -107%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 19.3M shares +8.76%
Common Stock, Shares, Outstanding 19.1M shares +8.83%
Entity Public Float 1.1B USD +22.2%
Common Stock, Value, Issued 20K USD +11.1%
Weighted Average Number of Shares Outstanding, Basic 18.3M shares +5.74%
Weighted Average Number of Shares Outstanding, Diluted 18.3M shares +3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 167M USD +27.3%
Research and Development Expense 21.4M USD -12.7%
General and Administrative Expense 78.7M USD +49%
Operating Income (Loss) -22.6M USD -289%
Nonoperating Income (Expense) 25.1M USD -51.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 2.52M USD -96%
Income Tax Expense (Benefit) 6.55M USD -33.4%
Net Income (Loss) Attributable to Parent -4.03M USD -108%
Earnings Per Share, Basic -0.22 USD/shares -107%
Earnings Per Share, Diluted -0.22 USD/shares -107%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 72.3M USD +215%
Accounts Receivable, after Allowance for Credit Loss, Current 38.4M USD +16.6%
Inventory, Net 14.1M USD -41.1%
Other Assets, Current 16.9M USD +536%
Assets, Current 332M USD +39.6%
Deferred Income Tax Assets, Net 72K USD -66.4%
Property, Plant and Equipment, Net 15.1M USD -3.04%
Operating Lease, Right-of-Use Asset 6.91M USD +13.9%
Intangible Assets, Net (Excluding Goodwill) 267M USD -11%
Goodwill 105M USD +1.82%
Other Assets, Noncurrent 6.92M USD +8.32%
Assets 942M USD +19.6%
Accounts Payable, Current 5.23M USD +116%
Employee-related Liabilities, Current 5.52M USD +17.9%
Accrued Liabilities, Current 27.9M USD +124%
Contract with Customer, Liability, Current 1.28M USD +4.58%
Liabilities, Current 37.1M USD +121%
Contract with Customer, Liability, Noncurrent 15.9M USD +16.3%
Deferred Income Tax Liabilities, Net 32.5M USD +2.85%
Operating Lease, Liability, Noncurrent 5.82M USD +1.04%
Other Liabilities, Noncurrent 30.2M USD +8.66%
Liabilities 111M USD +29%
Accumulated Other Comprehensive Income (Loss), Net of Tax -5.94M USD -627%
Retained Earnings (Accumulated Deficit) 499M USD -0.8%
Stockholders' Equity Attributable to Parent 830M USD +18.5%
Liabilities and Equity 942M USD +19.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 18.7M USD -44.8%
Net Cash Provided by (Used in) Financing Activities 12.2M USD
Net Cash Provided by (Used in) Investing Activities -3.78M USD -136%
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 19.1M shares +8.83%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 27.1M USD -37.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 72.3M USD +215%
Interest Paid, Excluding Capitalized Interest, Operating Activities 59K USD
Deferred Tax Assets, Valuation Allowance 55.6M USD -3.55%
Deferred Tax Assets, Gross 96.3M USD -7.15%
Operating Lease, Liability 7.08M USD +15%
Payments to Acquire Property, Plant, and Equipment 105K USD -95.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -9.16M USD -118%
Lessee, Operating Lease, Liability, to be Paid 9.48M USD +7.57%
Property, Plant and Equipment, Gross 23.4M USD +5.12%
Operating Lease, Liability, Current 1.27M USD +214%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.64M USD +37.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.54M USD +46.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.98M USD -11.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.63M USD +33.3%
Deferred Tax Assets, Operating Loss Carryforwards 40.4M USD -11.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 22.5M USD +0.48%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.56M USD +23.8%
Additional Paid in Capital 337M USD +69.8%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 8.77M USD -7.73%
Deferred Tax Assets, Net of Valuation Allowance 40.7M USD -11.7%
Interest Expense 557K USD -55.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%